D&D Pharmatech, a South Korean biotechnology company, has raised a $137 million Series B round from a group of Korean and US investors.
US-based Octave Life Sciences co-led the funding round with Korea’s Smilegate Investment, while InterVest, Magna Investment, and LB Investment participated as well. All of the investors participated...
01VC has secured institutional LP support for its second fund, which closed at $100 million. The early-stage investor plans to deploy it across industrial and enterprise deals in China and Southeast Asia
Singapore hotel management and booking platform RedDoorz has raised $70 million in Series C funding less than a month after closing a $45 million Series B.
LBNCo, an Australian fiber optic network provider acquired last year by a consortium led by ROC Partners, will be sold to industry peer Uniti Wireless for A$100 million ($67.7 million).